Trial Profile
Clinical Trials Insight: 700036271
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Aug 2008
Price :
$35
*
At a glance
- Drugs Mipomersen (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Ionis Pharmaceuticals; Sanofi Genzyme
- 15 Aug 2008 New trial record.